Avantium N.V. (NL:AVTX)
:AVTX
Want to see NL:AVTX full AI Analyst Report?
AVTX Stock Chart & Stats
€7.05
<€0.01(0.23%)
At close: 4:00 PM EST
€7.05
<€0.01(0.23%)
Day’s Range― - ―
52-Week Range€4.94 - €13.20
Previous CloseN/A
Volume208.36K
Average Volume (3M)515.06K
Market Cap
€186.53M
Enterprise Value€171.85M
Total Cash (Recent Filing)€57.47M
Total Debt (Recent Filing)€165.06M
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding25,206,718
10 Day Avg. Volume262,999
30 Day Avg. Volume515,059
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.60
Price to Sales (P/S)6.22
P/FCF Ratio-1.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.40Price Target Upside-9.22% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.17
Revenue Forecast (FY)€43.19M
Bulls Say, Bears Say
Bulls Say
Proprietary Renewable Chemistry TechnologyOwning core catalytic and process IP for FDCA/PEF provides durable competitive advantage. These platform technologies can underpin licensing, long-term partnerships and scale-up of bio-based polymers, creating structural market entry barriers and potential recurring technology revenues once commercialized.
Diversified Technology-based Revenue ModelA multi-pronged revenue model (licensing/royalties, R&D services, product sales and potential grants) reduces single-source risk. Licensing and collaborations can generate recurring or milestone income as partners scale, supporting cash flow durability while product sales ramp gradually.
Improved Capital Cushion In 2025A material equity increase in 2025 strengthens the balance sheet and raises the company’s buffer against operating losses. A larger capital cushion enhances funding flexibility for scale-up and technology commercialization, lowering near-term solvency risk while commercialization progresses.
Bears Say
Persistently Negative Gross Profit And MarginsNegative gross profit across reporting years indicates production or cost structures currently exceed revenue, making margin recovery essential. Persistent operating losses imply the business model has not yet reached sustainable unit economics and will require structural margin improvement to be self-sustaining.
Weak And Declining Revenue TrajectoryA falling top line and material negative revenue growth suggest uneven commercialization and demand execution. For a technology-to-market transition, consistent revenue ramp is critical; continued volatility or decline undermines ability to absorb fixed costs and delays path to positive margins and partner-driven scale.
Meaningful Leverage And Funding DependenceElevated debt and continued need for external funding constrain financial flexibility and increase refinancing risk, especially given ongoing losses. High leverage amplifies downside if revenue or cash generation stalls, potentially forcing dilutive equity raises or restructuring that could impede long-term strategy execution.
AVTX FAQ
What was Avantium N.V.’s price range in the past 12 months?
Avantium N.V. lowest stock price was €4.94 and its highest was €13.20 in the past 12 months.
What is Avantium N.V.’s market cap?
Avantium N.V.’s market cap is €186.53M.
When is Avantium N.V.’s upcoming earnings report date?
Avantium N.V.’s upcoming earnings report date is Aug 19, 2026 which is in 111 days.
How were Avantium N.V.’s earnings last quarter?
Avantium N.V. released its earnings results on Mar 18, 2026. The company reported -€0.616 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.616.
Is Avantium N.V. overvalued?
According to Wall Street analysts Avantium N.V.’s price is currently Overvalued.
Does Avantium N.V. pay dividends?
Avantium N.V. does not currently pay dividends.
What is Avantium N.V.’s EPS estimate?
Avantium N.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avantium N.V. have?
Avantium N.V. has 25,206,718 shares outstanding.
What happened to Avantium N.V.’s price movement after its last earnings report?
Avantium N.V. reported an EPS of -€0.616 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.189%.
Which hedge fund is a major shareholder of Avantium N.V.?
Currently, no hedge funds are holding shares in NL:AVTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Avantium N.V.
Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, the company R&D system, services, and refinery catalyst testing services. Further, it develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, the company produces polyesters using plantMEG. Avantium N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
AVTX Stock 12 Month Forecast
Average Price Target
€6.40
▼(-9.22% Downside)
Technical Analysis
AMG ADVANCED METALLURGICAL GROUP NV
―
Corbion NV
―
Holland Colours N.V.
―
IMCD N.V.
―
OCI N.V.
―
Options Prices
Currently, No data available
---